16:33:44 EDT Fri 15 May 2026
Enter Symbol
or Name
USA
CA



Diagnamed Holdings Corp
Symbol DMED
Shares Issued 109,158,973
Close 2026-05-14 C$ 0.07
Market Cap C$ 7,641,128
Recent Sedar+ Documents

Diagnamed Holdings closes Colchester East acquisition

2026-05-15 14:19 ET - News Release

Mr. John Karagiannidis reports

DIAGNAMED COMPLETES ACQUISITION OF COLCHESTER EAST NATURAL HYDROGEN PROJECT IN NOVA SCOTIA

Diagnamed Holdings Corp. has closed its previously announced (see press release of Dec. 10, 2025) acquisition of the Colchester East natural hydrogen project, consisting of 30 licences totalling 2,104 claims located within the Cumberland basin in Nova Scotia.

Pursuant to the closing of the acquisition, the company acquired the property by paying: (i) $10,000 in cash; and (ii) issuing an aggregate of 10 million common shares at an issue price of six cents per share, being the closing price of the common shares of the company on the Canadian Securities Exchange on the date immediately preceding the closing date. The two arm's-length vendors of the property each received five million common shares, which are subject to a statutory four-month-and-one-day hold period.

In addition, the vendors were granted a 2.0-per-cent gross revenue royalty on hydrogen, helium or any other mineral product sold from the property. The company may purchase, at its sole option, 50 per cent of the royalty at any time for $2-million.

This strategic acquisition positions Diagnamed directly within Canada's most active and rapidly expanding natural hydrogen corridor -- a region that has seen increased exploration interest.

The acquisition also complements Diagnamed's existing land position in Ontario's Temiscamingue hydrogen corridor and supports the company's strategy to advance next-generation natural hydrogen extraction technologies.

Grant of options

Diagnamed also announces that the board of directors has today granted an aggregate of seven million options at an exercise price of 7.5 cents to certain directors, officers and service providers. The options are exercisable for a term of two years.

About Diagnamed Holdings Corp.

Diagnamed is a Canadian technology innovator focused on developing advanced natural hydrogen extraction technologies to support the rapidly growing hydrogen sector. The company is committed to delivering scalable, cost-efficient and sustainable solutions essential to global energy security and decarbonization.

We seek Safe Harbor.

© 2026 Canjex Publishing Ltd. All rights reserved.